Education
About Us
Working with TipRanks
Follow Us
Fate Therapeutics Inc (FATE)
:FATE
FATE Analyst Ratings
Hold
2 Buy
8 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
FATE Stock 12 Month Forecast
Average Price Target
$4.89
▲(325.22%Upside)
| Highest Price Target$12.00 | Average Price Target$4.89 | Lowest Price Target$2.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$1
Hold
-13.04%
Downside
Reiterated
07/18/25
Fate Therapeutics has a challenging financial situation with persistent losses and negative cash flow, weighing heavily on its stock score. Technical analysis shows neutral momentum with no clear trend, while valuation metrics are concerning due to negative earnings. However, positive corporate events provide some optimism for strategic growth and governance improvements.
H.C. Wainwright
$5
Hold
334.78%
Upside
Reiterated
07/02/25
Wells Fargo
$4
Hold
247.83%
Upside
Reiterated
06/12/25
TD Cowen
―
Hold
―
Reiterated
06/12/25
Barclays
$2
Buy
73.91%
Upside
Reiterated
06/12/25
Needham
―
Hold
―
Reiterated
06/12/25
Bank of America Securities
$2.5→$2.2
Hold
91.30%
Upside
Reiterated
06/11/25
Wedbush
$5
Hold
334.78%
Upside
Reiterated
05/14/25
Oppenheimer
―
Hold
―
Reiterated
05/14/25
Robert W. Baird
$5→$4
Hold
247.83%
Upside
Reiterated
05/14/25
Leerink Partners
$12
Buy
943.48%
Upside
Reiterated
05/14/25
Morgan Stanley
$5
Hold
334.78%
Upside
Reiterated
03/06/25
Jefferies
$10→$8
Buy
595.65%
Upside
Reiterated
03/06/25
Stifel Nicolaus
$5→$3
Hold
160.87%
Upside
Reiterated
03/06/25
Piper Sandler
$6
Buy
421.74%
Upside
Reiterated
03/06/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$1
Hold
-13.04%
Downside
Reiterated
07/18/25
Fate Therapeutics has a challenging financial situation with persistent losses and negative cash flow, weighing heavily on its stock score. Technical analysis shows neutral momentum with no clear trend, while valuation metrics are concerning due to negative earnings. However, positive corporate events provide some optimism for strategic growth and governance improvements.
H.C. Wainwright
$5
Hold
334.78%
Upside
Reiterated
07/02/25
Wells Fargo
$4
Hold
247.83%
Upside
Reiterated
06/12/25
TD Cowen
―
Hold
―
Reiterated
06/12/25
Barclays
$2
Buy
73.91%
Upside
Reiterated
06/12/25
Needham
―
Hold
―
Reiterated
06/12/25
Bank of America Securities
$2.5→$2.2
Hold
91.30%
Upside
Reiterated
06/11/25
Wedbush
$5
Hold
334.78%
Upside
Reiterated
05/14/25
Oppenheimer
―
Hold
―
Reiterated
05/14/25
Robert W. Baird
$5→$4
Hold
247.83%
Upside
Reiterated
05/14/25
Leerink Partners
$12
Buy
943.48%
Upside
Reiterated
05/14/25
Morgan Stanley
$5
Hold
334.78%
Upside
Reiterated
03/06/25
Jefferies
$10→$8
Buy
595.65%
Upside
Reiterated
03/06/25
Stifel Nicolaus
$5→$3
Hold
160.87%
Upside
Reiterated
03/06/25
Piper Sandler
$6
Buy
421.74%
Upside
Reiterated
03/06/25
Best Analysts Covering Fate Therapeutics
1 Month
xxx
Success Rate
11/29 ratings generated profit
Average Return
-2.92%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 37.93% of your transactions generating a profit, with an average return of -2.92% per trade.
3 Months
xxx
Success Rate
12/29 ratings generated profit
Average Return
+0.34%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 41.38% of your transactions generating a profit, with an average return of +0.34% per trade.
1 Year
Success Rate
5/19 ratings generated profit
Average Return
-20.00%
reiterated a buy rating last month
Copying Peter Lawson's trades and holding each position for 1 Year would result in 26.32% of your transactions generating a profit, with an average return of -20.00% per trade.
2 Years
xxx
Success Rate
3/19 ratings generated profit
Average Return
-49.94%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 15.79% of your transactions generating a profit, with an average return of -49.94% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
FATE Analyst Recommendation Trends
Rating
Feb 25
Mar 25
May 25
Jun 25
Jul 25
Strong Buy
4
6
7
6
2
Buy
0
0
0
1
1
Hold
2
9
15
21
13
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
6
15
22
28
16
Each month's total comprises the sum of three months' worth of ratings.
FATE Financial Forecast
FATE Stock Forecast FAQ
What is FATE’s average 12-month price target, according to analysts?
Based on analyst ratings, Fate Therapeutics Inc’s 12-month average price target is 4.89.
What is FATE’s upside potential, based on the analysts’ average price target?
Fate Therapeutics Inc has 325.22% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is FATE a Buy, Sell or Hold?
Fate Therapeutics Inc has a consensus rating of Hold which is based on 2 buy ratings, 8 hold ratings and 0 sell ratings.
What is Fate Therapeutics Inc’s price target?
The average price target for Fate Therapeutics Inc is 4.89. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $12.00 ,the lowest forecast is $2.00. The average price target represents 325.22% Increase from the current price of $1.15.
The highest analyst price target is $12.00 ,the lowest forecast is $2.00. The average price target represents 325.22% Increase from the current price of $1.15.
What do analysts say about Fate Therapeutics Inc?
Fate Therapeutics Inc’s analyst rating consensus is a Hold. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of FATE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.